Anti-Human CD261 Azide Free

Product Specifications

Catalogue N°: 852.980.000 - 200µg / 200µl
852.980.005 - 500µg / 500µl
Target species: Human
Specificity: Recognises a 43-46 kDa protein
Clone: B-N28
Application: Immuno-Precipitation; Western Blot
Hybridoma: Myeloma X63/AG.8653 x Balb/c spleen cells
Immunisation: Recombinant human TRAIL R1/Fc chimera
Quantity: 200µg or 500µg (Discovery Size also available please enquire)
Isotype: Mouse IgG1 Kappa light chain
Format: Phosphate-buffered saline. Sterile-filtered through 0.22 µm. Carrier and preservative free
Workshop: VIII
Storage: Stable at +2-8°C for 12 months
Synonym: DR4; TRAIL R1

References

Chen, S. et al., Mol Cancer,2010;Jan 29;9:23 - Pubmed link
Chen, S. et al., Mol. Pharmacol.,2007; 72(5): 1269-1279. - Pubmed link
Dhandapani, L. et al.,Cancer Res., 2011; 71: 5245 - 5254 - Pubmed link
Dufour, F. et al., Cell Death Differ.,2017; 24(3): 500-510 - Pubmed link
Fan, S. et al., Neoplasia,2010; 12(4): 346-56 - Pubmed link
Fu, L. et al.,Mol Cancer,2010; 9: 31 - Pubmed link
Han, B. et al.,Oncotarget,2015;6(19): 17532-42 - Pubmed link
Iurlaro, R. et al.,Mol Cell Biol. 2017 May 2;37(10). pii: e00479-16. - Pubmed link
Kauh, J. et al., PLoS One,2010;5(4): e10376 - Pubmed link
Li, B. et al., Cancer Prevention Research, 2012; 5: 612 - 620 - Pubmed link
Lin, Y.-D. et al., Cancer Res.,2008; 68(13): 5335-5344. - Pubmed link
Oh, Y. T. et al., Oncotarget,2015; 6(38): 41324-38 - Pubmed link
Qi, L. et al.,Apoptosis,2011; 16(11): 1150-64 - Pubmed link
Raja, S. M. et al., Mol. Cancer Ther.,2008; 7(7): 2212-2223. - Pubmed link
Vermot-Desroches C. et al., Cell Immunol., 2005;236(1-2):86-91 - Pubmed link
Wang, W. et al.,Oncotarget,2016; 7(16): 21728-41. - Pubmed link
Yao, W. et al.,Oncotarget,2015; 6(33): 34669-79 - Pubmed link
Zhao, L. et al., Mol. Cancer Ther.,2011;10(12): 2415-2425 - Pubmed link
Zhao, L. et al.,Cancer Res.,2013; 73(6): 1946-1957 - Pubmed link

BACKGROUND

Human TRAIL R1/DR4, CD261 or DR4 (Death Receptor 4) is a TNF receptor, which is a receptor for TRAIL (APO2 ligand). TRAIL R1 is involved in apoptosis. In the TRAIL receptor family, TRAIL R1, but also TRAIL R2 (DR5) transduce an apoptosis signal, whereas TRAIL R3 (DcR1) and TRAIL R4 (DcR2) antagonize TRAIL-induced apoptosis. Binding of trimeric TRAIL to TRAIL R1 induces apoptosis by oligomerization (likely to be trimerization) of the receptor. TRAIL R1 cDNA encodes a 468 amino acid residue precursor protein containing extracellular cysteine-rich domains, a transmembrane domain and a cytoplasmic death domain. TRAIL R1 shares 55% of its amino acid sequence with TRAIL R2. TRAIL R1 is widely expressed in normal tissue.

Version 16 - 04.20

For research use only

Product Specifications

References

Related products

Documents

Formats Available

Ordering options

Distributors

Product search